Wordt geladen...

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Patients with antiphospholipid syndrome are at increased risk for recurrent arterial and venous thrombosis and therefore benefit from long term warfarin therapy. The optimal duration of warfarin therapy after a first venous thromboembolic event is however a matter of some controversy and many questi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Fonseca, Ana G, D'Cruz, David P
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2008
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2632629/
https://ncbi.nlm.nih.gov/pubmed/19014462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1740-2557-5-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!